Feed / EW

Edwards Lifesciences Corporation

EW

Healthcare · 89.79 +0.0% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Edwards Lifesciences Corporation's move is being confirmed by its market group.

EW accounts for 4.0% of the group's measured movement across 9.8 effective names. raw member direction is mixed; 10 of 12 session-normalized paths align to the upside. Capital-flow agreement is 21%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveAligned contributor#11 of 12 by movement share
Group movement share4.0%Absolute path energy—not portfolio weight
Relative path+0.77%aligned
Effective breadth9.8 / 12broad
Relative alignment10/12upside path · 1 counter-moving
Capital-flow agreement21%not yet clean
SEQUENCE READ

No material onset for EW could be timestamped inside the aligned 5-minute window.

What changed
  • Revenue increased 13.6% versus the comparable filing period.
  • Net income decreased 27.4% versus the comparable filing period.
EVIDENCE COVERAGE

9 of 18 members in Medical Devices & Supplies are active. 0 of 8 disclosed connections are confirming.

What would change this read
  • At least 12 of 18 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as AVNS begins moving with the group.

Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.

Watch this read

Who this business touches

The relationships behind EW

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BDXBecton, Dickinson and CompanycustomerMay 6, 2026 ▾

“We sold (i) our Critical Care product group (“Critical Care”) to Becton, Dickinson and Company (“BD”) in September 2024 and (ii) a business that was not focused on implantable medical innovations for structural heart diseases (the “non-core product group”) in…”

BDXBecton, Dickinson and CompanypartnerFeb 25, 2026 ▾

“On September 3, 2024, we sold our Critical Care product group (“Critical Care”) to Becton, Dickinson and Company (“BD”).”

Depended on by

AORTArtivion, Inc.competitorMay 8, 2026 ▾

“We compete with bioprosthetic or mechanical valves from companies including Medtronic, Edwards Lifesciences, Corcym, and Abbott Laboratories.”

Filing peers

AORTTFXMMSI

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

EW is currently a Participant in the organic co-movement group Medical Devices & Supplies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.